You searched for "occlusion"
AOP responds to new findings on bullying, harassment and discrimination in optics
The AOP endorses a commitment to more inclusive work environments for members – highlighting resources that tackle bullying and discrimination at work.Outcomes of corneal cross-linking in paediatric patients compared to fellow untreated eyes
This retrospective cohort study evaluated long-term visual, refractive, topographic and safety outcomes of corneal cross-linking (CXL) in patients younger than 18-years-old with keratoconus. The study included all consecutive paediatric patients who underwent epithelium-off CXL treatment for keratoconus at the study...Visual Fields via the Visual Pathway (Second Edition)
1 April 2017
| Fiona Rowe (Prof)
|
EYE - Glaucoma
This book is a very well-written and comprehensive text on visual field assessment and interpretation. It includes a large number of illustrations which are of a high quality and make it a good reading experience. The first section of the...
Retrograde maculopathy in glaucoma
1 October 2017
| Chrysostomos D Dimitriou
|
EYE - Glaucoma
Macular optical coherence tomography (OCT) analysis can be used for quantitative measures of optic nerve atrophy at a location far away from the optic nerve head. This has recently led to the discovery of microcystic macular oedema (MME), in the...
50 Studies Every Ophthalmologist Should Know
1 February 2022
| Nixon Yang
|
Ophthalmology
This book features a compilation of 50 important clinical studies that have left a profound impact on the current clinical practice of ophthalmology. From the 1980 botulinum toxin injection study by AB Scott to the United Kingdom Glaucoma Treatment Study...
Does the length of the school day have a role in age of myopia onset?
6 February 2024
| Lauren R Hepworth
|
Paediatric Ophthalmology / Strabismus
The authors prospectively collected the refractive data of myopic adults attending recruiting dispensing optician or ophthalmologist sites. Participants were recruited consecutively, giving verbal informed consent. Sites included a mix of urban and rural areas across eight sites. The following data...
5-FU vs. Avastin as adjunct to conjunctival autograft
The authors compare the outcome of pterygium treatment using 5-fluorouracil as an adjunct to free conjunctival autograft versus bevacizumab (Avastin) as an adjunct to free conjunctival autograft, via a randomised controlled prospective study. Seventy eyes of 70 patients were included...The power of the full blood count
Vishal Shah walks us through his thought process whilst highlighting the importance of routine investigations when dealing with unusual retinovascular presentations. Retinal changes can arise in anaemia, leukaemia, lymphoma, myeloproliferative and myelodysplastic syndrome. They are often the first manifestation of...The impact of obstructive sleep apnoea monitoring functionality on smartwatches: a new frontier for ophthalmologists
3 June 2024
| Yu Jeat Chong, Matthew Azzopardi
|
EYE - General
Dawn of a new era in wearable technology? Smartwatches have really stepped up their game and have evolved from telling time to keeping an eye on our health. In February 2024, the United States Food and Drug Administration (FDA) gave...
Comparison of vision screening programmes
1 December 2018
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
|
Amblyopia treatment, orthoptists, vision screening/diagnosis
The purpose was to examine the treatment that children underwent as a result of being identified with reduced vision at school screening. The level of improvement in vision was identified and the time taken to achieve maximum visual acuity. There...
An educational intervention to improve adherence to high-dosage patching regimen for amblyopia
1 December 2014
| Jonathan Chan
|
Paediatric Ophthalmology / Strabismus
This is a randomised trial of patients recruited between the periods of March 2006 and March 2008 from ophthalmology clinics in the Leicestershire area. A total of 62 children with newly diagnosed amblyopia were allocated randomly into two treatment arms...
Intravitreal Ziv-Aflibercept: safety analysis
7 December 2020
| Su Young
|
EYE - Vitreo-Retinal
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...